The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 116 participants.
Also called NCT07314047
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 116 participants
- Registry
-
NCT07314047
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07314047. Randomized; no masking; primary purpose treatment. Start 2024-05-28 (actual); primary completion 2025-05-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation
- Acronym
- PARTNER
- Condition
- Brain Arteriovenous Malformation
- Condition
- Arteriovenous Fistula
- Intervention (Device)
- liquid embolic agent
- Lead sponsor
- MicroPort NeuroTech Co., Ltd.
Record details
- Record id
cardio:ct-nct07314047- Content hash
7696ffa28d8afa3996e8379a5b19440c1707c81f01e69084a5f1caa68b03d73a